Peer-reviewedCC BYJournal for ImmunoTherapy of Cancer
860 mRNA-LNP-mediated immunomodulation for precision cancer vaccines and immunotherapy
- 1University of Houston, Houston, TX, USA
- 2Massachusetts Institute of Technology, Cambridge, MA, USA
- 3Massachusetts General Hospital, Boston, MA, USA
Related
- PROTAC‐Engineered Protein/DNA Nanoantigen is a Potent Booster for Dendritic Cell Vaccines in Cancer Immunotherapy
- Precision targeting of tumor-associated macrophages via a 6-substituted pyrrolo[2,3-d]pyrimidine chimeric molecule for enhanced cancer immunotherapy
- Personalized cancer vaccines: bridging immune-oncology and precision medicine for advanced therapeutics
- Molecular Checkpoints of Nucleic Acid Sensing in Tumor Cells: Linking Innate Immune Evasion to Precision Cancer Immunotherapy
- Tumor antigens across cancer progression: from immune recognition and selection to precision cancer immunotherapy
BibTeX
@article{gupta2026mrnalnpmediated,
title = {{860 mRNA-LNP-mediated immunomodulation for precision cancer vaccines and immunotherapy}},
author = {Akash Gupta and Kaelan Reed and Daniel Anderson and Riddha Das and Christopher S Garris},
journal = {Journal for ImmunoTherapy of Cancer},
year = {2026},
month = nov,
doi = {10.1136/jitc-2026-sitc2026.0860},
url = {https://doi.org/10.1136/jitc-2026-sitc2026.0860},
note = {CC BY},
}
RIS
TY - JOUR
TI - 860 mRNA-LNP-mediated immunomodulation for precision cancer vaccines and immunotherapy
AU - Akash Gupta
AU - Kaelan Reed
AU - Daniel Anderson
AU - Riddha Das
AU - Christopher S Garris
PY - 2026
DA - 2026/11/06
JO - Journal for ImmunoTherapy of Cancer
DO - 10.1136/jitc-2026-sitc2026.0860
UR - https://doi.org/10.1136/jitc-2026-sitc2026.0860
SN - 2051-1426
ER -